High tumor cell expression of PD-L1 might be associated with inferior survival in DLBCL due to immune evasion of the tumor cells, and high numbers of PD-1+ TILs in DLBCL might reflect an immunologically active TME, which is prone to respond to chemotherapy. This evidence concerns the gene PDCD1 and neoplasm.